2006.4-至今，復(fù)旦大學(xué)生命科學(xué)學(xué)院與生物醫(yī)學(xué)研究院，副教授；

2004.7-2006.3，復(fù)旦大學(xué)生命科學(xué)學(xué)院與生物醫(yī)學(xué)研究院，講師；

2003.7-2004.6，國家人類基因組北方研究中心，研究助理；

2000.9-2003.6，軍事醫(yī)學(xué)科學(xué)院放射與輻射醫(yī)學(xué)研究所，細(xì)胞生物學(xué)專業(yè)人類與醫(yī)學(xué)遺傳學(xué)方向博士生，獲理學(xué)博士學(xué)位；

1997.9-2000.6,南京農(nóng)業(yè)大學(xué)動物醫(yī)學(xué)院，預(yù)防獸醫(yī)學(xué)專業(yè)分子病毒學(xué)方向碩士生，獲農(nóng)學(xué)碩士學(xué)位；

1993.9-1997.6, 湖北農(nóng)學(xué)院動物科學(xué)系，畜牧獸醫(yī)專業(yè)本科生，獲農(nóng)學(xué)學(xué)士學(xué)位；

研究領(lǐng)域包括復(fù)雜疾病的遺傳易感性，比較與進(jìn)化藥物基因組學(xué)，以及分子水平人類適應(yīng)性進(jìn)化。目前研究方向為P450和ABC轉(zhuǎn)運體等藥物代謝酶的進(jìn)化與功能基因組學(xué)。對疾病的遺傳分析，不僅需要從橫向的空間上分析不同群體或個體的遺傳變異對疾病譜和易感性的影響，而且需要在縱向的進(jìn)化歷史中，把疾病的自然史和人類的分子適應(yīng)性進(jìn)化結(jié)合起來，考察人類起源遷移的群體歷史中，動態(tài)變化的環(huán)境風(fēng)險因素對疾病相關(guān)基因的達(dá)爾文分子選擇。運用群體遺傳學(xué)與分子進(jìn)化的原理與方法，結(jié)合分子與細(xì)胞生物學(xué)的實驗手段，以及基于家系或群體的疾病連鎖與關(guān)聯(lián)分析，從多個水平研究“疾病遺傳與人類進(jìn)化”，不僅對探詢?nèi)祟愡M(jìn)化的自然史有重要理論意義，而且對了解包括腫瘤與心腦血管疾病等重大復(fù)雜疾病的病因?qū)W，以及疾病譜和藥物反應(yīng)性的群體差異，并最終促進(jìn)疾病群體預(yù)防和個體化治療，亦有重大現(xiàn)實意義。

2005年全國優(yōu)秀博士論文提名;

2005年軍隊科技進(jìn)步一等獎（第五完成人）；

2005年北京市科技進(jìn)步一等獎（第八完成人）；

2005年中華醫(yī)學(xué)科技二等獎（第八完成人）；

2005年第八屆“北京青年優(yōu)秀科技論文”一等獎；

1998年南京農(nóng)業(yè)大學(xué)“品學(xué)兼優(yōu)研究生”

（以發(fā)表時間為序，* 并列第一作者; §并列通訊作者）：

1.Haijian Wang*, Keyue Ding*, Yang Zhang, Li Jin, Iftikhar J. Kullo, Fuchu He. Comparative and Evolutionary Pharmacogenetics of ABCB1: Complex Signatures of Positive Selection on Coding and Regulatory Regions. (Pharmacogenet Genomics 2007, in press; SCI 2005 IF = 5.882)

2.Haijian Wang, Bingtao Hao, Xiaoping Chen, Naiqing Zhao, Gang Cheng, Yan Jiang, Yang Liu, Chengzhao Lin, Wen Tan, Daru Lu, Qingyi Wei, Li Jin, Dongxin Lin§, and Fuchu He§. Beta-2 adrenergic receptor gene (ADRB2) polymorphism and risk for lung adenocarcinoma: A case-control study in a Chinese population. Cancer Lett. 2006; 240: 297-305. (SCI 2005 IF = 3.049)

3.Haijian Wang, Yan Jiang, Yang Liu, Chengzhao Lin, Gang Cheng, Xiaoping Chen, Bingtao Hao, Wen Tan, Dongxin Lin§, and Fuchu He§. CYP2J2*7 single nucleotide polymorphism in a Chinese population. Clin Chim Acta 2006, 365:125-8. (SCI 2005 IF = 2.149)

4. Xiaoping Chen,Haijian Wang, Weimin Xie, Renxiang Liang, Zhongliang Wei, Lianteng Zhi, Xiumei Zhang, Bingtao Hao, Shaofei Zhong, Gangqiao Zhou, Lingqiang Zhang, Xue Gao, Yunping Zhu and Fuchu He. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China. Pharmacogenet Genomics 2006; 16:219-227. (SCI 2005 IF = 5.882)

5. Bingtao Hao, Xiaoping Miao, Yi Li, Xuemei Zhang, Tong Sun, Gang Liang, Yanlin Zhao, Yifeng Zhou,Haijian Wang, Xiaoping Chen, Lingqiang Zhang, Wen Tan, Qingyi Wei, Dongxin Lin, and Fuchu He. A Novel T-77C Polymorphism in XRCC1 Contributes to Diminished Promoter Activity and Increased Lung Cancer Susceptibility. (Oncogene 2006; 25: 3613-20, SCI 2005 IF = 6.872)

6. Xiaoping Chen, Liqing Wang, Lianteng Zhi, Gangqiao Zhou,Haijian Wang, Xiumei Zhang, Bingtao Hao, Yunping Zhu Zeneng Cheng, Fuchu He. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population. Clin Pharmacol Ther. 2005; 78: 249-59. (SCI 2005 IF = 7.526)

7.Haijian Wang, Bingtao Hao, Kaixin Zhou, Xiaoping Chen, Songfeng Wu, Gangqiao Zhou, Yunping Zhu, and Fuchu He. Linkage disequilibrium and haplotype architecture for two ABC transporter genes (ABCC1 and ABCG2) in Chinese population: implications for pharmacogenomic association study. Ann Hum Genet. 2004, 68: 563-573. (SCI 2003 IF = 3.102)

8. Bingtao Hao,Haijian Wang, Kaixin Zhou, Yi Li, Xiaoping Chen, Gangqiao Zhou, Yunping Zhu, Xiaoping Miao, Wen Tan, Qingyi Wei, Dongxin Lin§, and Fuchu He§. Identification of Genetic Variants in Base Excision Repair Pathway and Their Associations with Risk of Esophageal Squamous Cell Carcinoma. Cancer Res. 2004, 64(12): 4378-4384. (SCI 2003 IF = 8.649)

9.Haijian Wang*, Wen Tan*, Bingtao Hao, Xiaoping Miao, Gangqiao Zhou, Fuchu He§, and Dongxin Lin§. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active Cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res. 2003, 63(22): 8057-8061. (SCI 2002 IF = 8.318)

10. Guo-Lin Chen*,Haijian Wang*, Wei Wang, Zhen-Hua Xu, Gan Zhou, Fuchu He§, and Hong-Hao Zhou§. Histamine N-methyltransferase gene polymorphisms in Chinese and their relationship with enzyme activity in erythrocyte. Pharmacogenet; 2003, 13 (7): 389-397. (SCI 2002 IF = 5.540)

11. Heyi Yang,Haijian Wang, Jie Wang, Yun Cai, Gangqiao Zhou, Fuchu He and Xiaohong Qian. Multiplex single-nucleotide polymorphism genotyping by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem 2003; 314(1): 54-62. (SCI 2002 IF = 2.370)

12. 汪海健, 賀福初. 生物異源物傳感系統(tǒng)研究進(jìn)展. 生命的化學(xué). 2003; 23(2): 97-99.